monkeys

Animal tests of an expected COVID-19 vaccine being developed by Chinese researchers demonstrate it triggers an immune reaction against the novel coronavirus, offering some promise since it goes into early-stage human trials, according to a peer-reviewed study. ARCoV is a messenger RNA vaccine which uses technology like applicants being manufactured by Moderna and BioNtech and …